Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

Clinical trial NCT02348723 · COMPLETED

Trial details

NCT number: NCT02348723
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2015-04-28
Primary completion: 2016-11-11
Enrollment: 678

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.